(Q43729213)

14 June 2018

title

Sensitivity and specificity of mass screening for gastric cancer using the measurment of serum pepsinogens (English)

1 reference

14 June 2018

author name string

Y Hattori

1

1 reference

14 June 2018

H Tashiro

2

1 reference

14 June 2018

T Kawamoto

3

1 reference

14 June 2018

Y Kodama

4

1 reference

14 June 2018

publication date

1 December 1995

1 reference

14 June 2018

number of pages

6

1 reference

Japanese Journal of Cancer Research

inferred from page(s)

published in

1 reference

14 June 2018

volume

86

1 reference

14 June 2018

issue

12

1 reference

14 June 2018

page(s)

1210-1215

1 reference

14 June 2018

The serum pepsinogen level with special reference to the histology of the gastric mucosa

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920667

Carcinoma arising from areas of intestinal metaplasia in the gastric mucosa

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920667

Basic issues in population screening for cancer

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920667

A clinical and statistical follow-up study of atrophic gastritis.

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920667

UICC workshop of the Project on Evaluation of Screening Programmes for Gastrointestinal Cancer.

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920667

Evaluation of a mass screening program for stomach cancer with a case-control study design

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920667

Serum pepsinogens as a screening test of extensive chronic gastritis.

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920667

The decline in gastric cancer: epidemiology of an unplanned triumph

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920667

Evaluation of a mass screening program for stomach cancer

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920667

The significance of low serum pepsinogen levels to detect stomach cancer associated with extensive chronic gastritis in Japanese subjects.

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920667

A prospective study of atrophic gastritis and stomach cancer risk

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920667

Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer.

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920667

15 August 2018

The value of screening

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920667

Estimation of validity of mass screening program for gastric cancer in Osaka, Japan

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920667

Serum pepsinogen I as a predictor of stomach cancer

15 August 2018

1 reference

12 December 2020

Chronic gastritis in Japanese with reference to high incidence of gastric carcinoma

1 reference

12 December 2020

Estimates of the worldwide frequency of sixteen major cancers in 1980

1 reference

12 December 2020

[Estimation of frequency, population doses and stochastic risks in stomach mass screening examinations in Japan, 1980]

1 reference

12 December 2020

Atrophic chronic gastritis and intestinal metaplasia in gastric carcinoma. Comparison with a representative population sample

1 reference

12 December 2020

Chronological Transition of the Fundic-Pyloric Border Determined by Stepwise Biopsy of the Lesser and Greater Curvatures of the Stomach

1 reference

12 December 2020

Serum and gastric mucosal pepsinogens in atrophic gastritis, particularly in type A gastritis associated with pernicious anemia in Japanese

1 reference

12 December 2020

Atrophic gastritis as a possible precursor of gastric carcinoma and pernicious anemia. Results of follow-up examinations

1 reference

12 December 2020

[Evaluation of serum pepsinogen I and II of patients with gastric cancer]

1 reference

12 December 2020

A long-term follow-up study of patients with gastric cancer detected by mass screening

1 reference

12 December 2020

Correlation between the prevalence of gastritis and gastric cancer in Japan

1 reference

12 December 2020

Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia

1 reference

12 December 2020

Serum pepsinogen as a new marker for gastric carcinoma among young adults. Research Group on Prevention of Gastric Carcinoma among Young Adults

1 reference

12 December 2020

Serum pepsinogens I and II and stomach cancer

1 reference

12 December 2020

Precancerous gastric lesions in a population at high risk of stomach cancer

1 reference

12 December 2020

10.1111/J.1349-7006.1995.TB03317.X

Identifiers

DOI

1 reference

14 June 2018

PMCID

5920667

1 reference

14 June 2018

PubMed ID

8636012

1 reference

14 June 2018